Methotrexate given concurrently with radiotherapy in the treatment of transitional cell carcinoma.
Tomlinson
M J
MJ
Department of Radiotherapy, Bristol Royal Infirmary.
Lancaster
J F
JF
Bullimore
J A
JA
Smith
P J
PJ
D000328:Adult; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*
D008727:Methotrexate